Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.140
+0.020 (0.64%)
Oct 11, 2024, 4:00 PM EDT - Market closed
Evotec SE Revenue
Evotec SE had revenue of 182.12M EUR in the quarter ending June 30, 2024, with 6.96% growth. This brings the company's revenue in the last twelve months to 788.44M, down -1.25% year-over-year. In the year 2023, Evotec SE had annual revenue of 781.43M with 3.99% growth.
Revenue (ttm)
788.44M EUR
Revenue Growth
-1.25%
P/S Ratio
n/a
Revenue / Employee
155,788 EUR
Employees
5,061
Market Cap
1.09B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
Dec 31, 2022 | 751.45M | 133.41M | 21.59% |
Dec 31, 2021 | 618.03M | 117.11M | 23.38% |
Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
Dec 31, 2019 | 446.44M | 71.03M | 18.92% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Brookdale Senior Living | 2.92B |
U.S. Physical Therapy | 621.23M |
The Pennant Group | 611.81M |
Collegium Pharmaceutical | 576.65M |
Phreesia | 389.96M |
Silk Road Medical | 191.43M |
Establishment Labs Holdings | 151.35M |
Calliditas Therapeutics AB | 151.09M |
EVO News
- 17 days ago - Novo Nordisk And Evotec Collaborate On Stem Cell-Based Therapy Development - Benzinga
- 17 days ago - Evotec and Novo Nordisk forge technology development partnership - Reuters
- 17 days ago - Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies - Accesswire
- 23 days ago - Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU) - Accesswire
- 4 weeks ago - Scientist.com and Evotec Partner to Accelerate Drug Discovery and Development - Business Wire
- 5 weeks ago - Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery - Business Wire
- 5 weeks ago - Evotec Announces Change in Management Board - Accesswire
- 6 weeks ago - Evotec: Weak Performance, But Long-Term Potential Is There - Seeking Alpha